Add to ORKGObjective: Although it is well known that GSK3b participates in the proliferation and survival of various tumor cells, its role in diseases of the central nervous system has been sparsely documented. In the past few years, studies regarding the relationship between GSK3b rs334558 T>C and rs6438552 C>T polymorphisms and Alzheimer disease (AD) risk have yielded contradictory results. As such, this meta-analysis seeks to satisfy the need to further investigate this relationship. Methods: In this research, published studies regarding the association of GSK3b rs6438552 and rs334558 mutation with AD risk was systematically assessed
Background: Glycogen synthase kinase 3 (GSK-3) is the evolutionary well-preserved multifunctional ub...
Copyright © 2014 Fabio Coppede ̀ et al.This is an open access article distributed under the Creative...
We undertook a two-stage genome-wide association study (GWAS) of Alzheimer's disease (AD) involving ...
Objective: Although it is well known that GSK3b participates in the proliferation and survival of va...
Background: Glycogen synthase kinase 3 beta (GSK3B) is the major kinase phosphorylating tau protein....
Background: Glycogen synthase kinase 3 beta (GSK3B) is the major kinase phosphorylating tau protein....
Copyright © 2011 Roberto Dominici et al. This is an open access article distributed under the Creati...
" These authors should be regarded as co-first authors. Recently, a large meta-analysis of five...
Originally discovered because of its role in the regulation of glucose metabolism, GSK-3 is now wide...
Background: Recently, GAB2 has been suggested to modify the risk of late-onset Alzheimer's disease (...
Context: Genome-wide association studies (GWAS) have recently identified CLU, PICALM, and CR1 as nov...
A large fraction of genetic risk factors for Alzheimer's Disease (AD) is still not identified, limit...
Contains fulltext : 69132.pdf (publisher's version ) (Closed access)Although the r...
Mutations in app, ps-1 and ps-2 genes result in the appearance of Familial Alzheimer disease (FAD). ...
Background: Glycogen synthase kinase 3 (GSK-3) is the evolutionary well-preserved multifunctional ub...
Background: Glycogen synthase kinase 3 (GSK-3) is the evolutionary well-preserved multifunctional ub...
Copyright © 2014 Fabio Coppede ̀ et al.This is an open access article distributed under the Creative...
We undertook a two-stage genome-wide association study (GWAS) of Alzheimer's disease (AD) involving ...
Objective: Although it is well known that GSK3b participates in the proliferation and survival of va...
Background: Glycogen synthase kinase 3 beta (GSK3B) is the major kinase phosphorylating tau protein....
Background: Glycogen synthase kinase 3 beta (GSK3B) is the major kinase phosphorylating tau protein....
Copyright © 2011 Roberto Dominici et al. This is an open access article distributed under the Creati...
" These authors should be regarded as co-first authors. Recently, a large meta-analysis of five...
Originally discovered because of its role in the regulation of glucose metabolism, GSK-3 is now wide...
Background: Recently, GAB2 has been suggested to modify the risk of late-onset Alzheimer's disease (...
Context: Genome-wide association studies (GWAS) have recently identified CLU, PICALM, and CR1 as nov...
A large fraction of genetic risk factors for Alzheimer's Disease (AD) is still not identified, limit...
Contains fulltext : 69132.pdf (publisher's version ) (Closed access)Although the r...
Mutations in app, ps-1 and ps-2 genes result in the appearance of Familial Alzheimer disease (FAD). ...
Background: Glycogen synthase kinase 3 (GSK-3) is the evolutionary well-preserved multifunctional ub...
Background: Glycogen synthase kinase 3 (GSK-3) is the evolutionary well-preserved multifunctional ub...
Copyright © 2014 Fabio Coppede ̀ et al.This is an open access article distributed under the Creative...
We undertook a two-stage genome-wide association study (GWAS) of Alzheimer's disease (AD) involving ...